Emergent BioSolutions Inc (EBS)
8.10
+0.04
(+0.50%)
USD |
NYSE |
Dec 20, 16:00
8.12
+0.02
(+0.25%)
After-Hours: 20:00
Emergent BioSolutions Shareholders Equity (Quarterly): 508.40M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Abbott Laboratories | 39.80B |
| Tonix Pharmaceuticals Holding Corp | 74.21M |
| Chimerix Inc | 135.78M |
| Geron Corp | 292.28M |
| MAIA Biotechnology Inc | 1.619M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.478B |
| Total Liabilities (Quarterly) | 969.40M |
| Debt to Equity Ratio | 1.303 |
| Current Ratio | 2.877 |
| Net Debt Paydown Yield | 10.66% |